Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Non-Current Deffered Revenue (2017 - 2018)

Cue Biopharma (CUE) has disclosed Non-Current Deffered Revenue for 2 consecutive years, with $9000.0 as the latest value for Q1 2018.

  • Quarterly Non-Current Deffered Revenue changed N/A to $9000.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $9000.0 through Mar 2018, changed N/A year-over-year, with the annual reading at $36000.0 for FY2017, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $9000.0 in Q1 2018 for Cue Biopharma, down from $36000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $36000.0 in Q4 2017 to a low of $9000.0 in Q1 2018.